This work is funded by the public via direct donations. There are now four usual methods of donation depending on the needs of the donor: Patreon, Bank Transfer, Stripe & PayPal. The email to use for PayPal is firstname.lastname@example.org
Crowdfunding platform Patreon allows for the donor to sign up regular donations and select their own level of support for monthly payment. I try to post monthly to the account to update donors on my latest work who are not visting my site or following me on Twitter. People who use this option tend to be those who prefer to be long term patrons of worthy projects or individuals and appreciate the convenience of set and forget, knowing they are taking care of those they value while leading busy lives. Some of my Patreon donors have been with me for years and I thank them for their longstanding generosity and commitment to keep the work I do.
485 746 256
Some people prefer to donate via Bank Transfer: bank transfer either as a one off payment or at regular intervals as then this avoids the fee to me that is charged by Patreon or for other personal reasons. It has the benefit of not having to sign up to a new platform.
It can be a good idea to contact me and let me know if you are concerned the details you entered aren't correct - to ensure your money reaches me as intended.
For people who just want a quick way to send money without signing up for anything or visiting a banking site, Stripe allows this via these buttons. The amount is set and is a one-off payment using credit card details. If you put in a valid email address then you should get a receipt. You should see AusGov.info on your bank statement details. The Stripe platform processes all financial information for a secure transation.
Privacy and your donation
Whether a donor is an individual or an organisation, I take privacy issues seriously. In order to avoid breaching people's sense of privacy, unless I am directly contacted about a donation by the donor, I do not thank them unless having a direct conversation about a donation.
Having said this, most people become donors when they read that someone they respect suggests they do. Please take a moment every now and then and, if you are happy to be seen publicly supporting my work, share my work with your networks. While I am yet to receive a minimum wage for what I do I want people to know that I am grateful for both the financial and moral support I receive.
Grants, Ministers and Portfolios in this data relate to the period prior to the 30 March resuffle. If my work receives adequate funding, grants awarded after that period will be added after those decisions are made & as time permits. Ministry & Portfolio names will be updated at that time.
Click on the head shot to drill down
39 Senior Ministers have administered the Health Portfolio
Bridget McKenzie Minister for Rural Health Minister for Sport Minister for Regional Communications
Ken Wyatt Minister for Aged Care Minister for Indigenous Health
Greg Hunt Minister for Health
Richard Colbeck Minister for Aged Care and Senior Australians Minister for Youth and Sport
Grants by the Health Portfolio by month
ABCM INNOVATIVE CLINICAL TRIALS GRANT OPPORTUNITY PROGRAM GRANTS BY MONTH
$1,749,170 in funding across 2 grants was allocated to 2 recipients of the Abcm Innovative Clinical Trials Grant Opportunity Program since January 2018
The Innovative Clinical Trials Grant Opportunity's purpose is to increase brain cancer clinical trial activity in Australia by supporting new, high quality research. Novel and innovative clinical trial methodologies are encouraged.
The Medical Research Future Fund (MRFF) provides grants of financial assistance to support health and medical research and innovation in improving the health and wellbeing of Australians. It operates as an endowment fund with the capital preserved in perpetuity. The MRFF aims to transform health and medical research and innovation to improve lives, build the economy and contribute to health system sustainability through targeted strategic investment across the research pipeline.
The independent and expert Australian Medical Research Advisory Board's Australian Medical Research and Innovation Strategy 2016-2021 and related Australian Medical Research and Innovation Priorities 2016-2018 were developed following extensive stakeholder consultation. The priorities identified by the Advisory Board were utilised to make decisions on the provision of financial assistance from the MRFF.
Brain cancer is the sixth leading cause of cancer burden and there are more than 100 types of brain cancer and other central nervous system cancers. These cancers carry high rates of morbidity and mortality. The five-year relative survival rate for brain cancer is low, at around 22 per cent and this rate has not improved for the past 30 years.
The young are disproportionately affected by brain cancer, being the leading cause of cancer-related deaths for those under 25 years of age. Every year in Australia the equivalent of a classroom of children die from brain cancer. The Australian Government is committed to improving survival rates and outcomes for both children and adults with brain cancer through ongoing investment in cancer control.
In October 2017, the Government established the Australian Brain Cancer Mission (the Mission). The aim of the Mission is to double survival rates and improve the quality of life of patients with brain cancer over 10 years to 2027, with the longer term aim of defeating brain cancer. Total funding for the Mission as at May 2019 stands at $124.65 million including $58.35 million in Australian Government funding under the MRFF. The remaining funds are being provided by philanthropy, other governments, industry and the private sector. Cancer Australia manages the implementation of the Mission, supported by a Strategic Advisory Group.
The Mission is underpinned by the Brain Cancer Research Roadmap, developed by Australian and international experts in brain cancer treatment and research, and those affected by brain cancer, their advocates and philanthropic interests.
One of the priorities under the investment strategy of Increased and Equitable Access and Participation in Clinical Trials, is to invest in, and expand, the capacity of innovative brain cancer research clinical trials of great potential. Clinical trials are fundamental to establishing whether new cancer treatments or new ways of using existing therapies, diagnostic tests, preventative or supportive interventions are effective, and whether they help generate the evidence for best-practice cancer care.